Accendra Health, Inc. (NYSE: ACH) reported Q1 EPS of ($0.04), $0.06 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $627.8 million versus the consensus estimate of $646.24 million.

The company is affirming its prior guidance for net revenue and adjusted EBITDA for the full year 2026.

For earnings history and earnings-related data on Accendra Health, Inc. (ACH) click here.